Who Paid My Doc
Gia Spiotto
Nurse Practitioner, Pediatrics Chicago, IL Nurse Practitioner
NPI 1386675114 CMS profile 10497098
225 E. Chicago Ave, Chicago, IL 60611
General payments
$3,312
Research payments
$0
Ownership & investment interest
$0
Through program year 2021, Gia Spiotto of Chicago, IL is reported in the CMS Open Payments database as having received $3,312 across 38 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 97th percentile of Nurse Practitioner, Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2021 | General | $3,312 | 38 |
Beside peers
- Gia Spiotto
- Nurse Practitioner, Pediatrics median
- Middle half of Nurse Practitioner, Pediatrics
- National median
In program year 2025, general payments to Gia Spiotto were reported at $0. Among 7,458 Nurse Practitioner, Pediatrics profiles paid that year, the median was $93 and the middle half received between $35 and $201.
Show as a table
| Year | Gia Spiotto | Nurse Practitioner, Pediatrics median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $3,312 | $60 | $23–$142 | $132 |
| 2022 | $0 | $72 | $27–$161 | $149 |
| 2023 | $0 | $89 | $35–$185 | $160 |
| 2024 | $0 | $93 | $34–$199 | $164 |
| 2025 | $0 | $93 | $35–$201 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
12
Drug cost
$68
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Warfarin Sodium | Generic | 12 | $68 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Records
38 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nurse Practitioner, Pediatrics in Illinois
Emily Simmons
Nurse Practitioner, Pediatrics · Chicago, IL
Theresa Mottes
Nurse Practitioner, Pediatrics · Chicago, IL
Stephanie Mensch
Nurse Practitioner, Pediatrics · Oak Lawn, IL
Christine Horne
Nurse Practitioner, Pediatrics · Chicago, IL
Danielle Oyasu
Nurse Practitioner, Pediatrics · Chicago, IL
Gail Kellberg
Nurse Practitioner, Pediatrics · Maywood, IL
Related records
Nurse Practitioner, Pediatrics in Illinois
Practitioners in the same specialty and state, ranked by reported value.
All Nurse Practitioner, Pediatrics
Everyone recorded under this specialty, nationwide.
Doctors in Illinois
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.